BCAS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.570600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.031000E-01
Normal-vs-Stage2
7.205400E-01
Normal-vs-Stage3
4.163400E-01
Normal-vs-Stage4
3.371200E-01
Stage1-vs-Stage2
9.905800E-01
Stage1-vs-Stage3
5.764600E-01
Stage1-vs-Stage4
1.933980E-01
Stage2-vs-Stage3
4.866400E-01
Stage2-vs-Stage4
1.198770E-01
Stage3-vs-Stage4
1.406150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.449000E-01
Normal-vs-AfricanAmerican
8.864200E-01
Normal-vs-Asian
7.463200E-01
Caucasian-vs-AfricanAmerican
5.022200E-01
Caucasian-vs-Asian
8.782400E-01
AfricanAmerican-vs-Asian
5.766800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.122400E-01
Normal-vs-Female
9.632800E-01
Male-vs-Female
7.484200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.907500E-02
Normal-vs-Age(41-60Yrs)
8.179600E-01
Normal-vs-Age(61-80Yrs)
6.072200E-01
Normal-vs-Age(81-100Yrs)
3.915000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.36010000000242E-05
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.275900E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.731200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.398000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.642100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.910600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.587000E-01
Normal-vs-Daily Drinker
5.411200E-01
Normal-vs-Weekly Drinker
3.792600E-01
Normal-vs-Occasional Drinker
5.670000E-01
Normal-vs-Social Drinker
6.343600E-01
Non Drinker-vs-Daily Drinker
2.723200E-01
Non Drinker-vs-Weekly Drinker
9.999400E-01
Non Drinker-vs-Occasional Drinker
1.776570E-03
Non Drinker-vs-Social Drinker
2.230200E-01
Daily Drinker-vs-Weekly Drinker
4.112000E-01
Daily Drinker-vs-Occasional Drinker
3.086500E-02
Daily Drinker-vs-Social Drinker
8.140400E-01
Weekly Drinker-vs-Occasional Drinker
2.071700E-02
Weekly Drinker-vs-Social Drinker
3.565400E-01
Occasional Drinker-vs-Social Drinker
8.279700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.323400E-01
Normal-vs-Grade 2
8.484800E-01
Normal-vs-Grade 3
9.084000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.505640E-01
Grade 1-vs-Grade 3
7.151600E-01
Grade 1-vs-Grade 4
9.323400E-01
Grade 2-vs-Grade 3
1.899780E-01
Grade 2-vs-Grade 4
8.484800E-01
Grade 3-vs-Grade 4
9.084000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.942400E-01
Normal-vs-NonDiabetic
7.313400E-01
Diabetic-vs-NonDiabetic
2.438600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.664400E-01
Normal-vs-NoPancreatitis
6.998200E-01
Pancreatitis-vs-NoPancreatitis
6.307200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.530000E-01
Normal-vs-N1
7.819200E-01
N0-vs-N1
7.987200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.302000E-01
Normal-vs-TP53-NonMutant
5.956600E-01
TP53-Mutant-vs-TP53-NonMutant
4.313600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
